Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME) | MicrobiomeTrials← Back to trialsNCT05282901
Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-07-07Est. Completion: 2025-04-28
Enrollment target: 51 participants Locations- Institut Curie, Paris, France
Other microbiome trials you might be interested in
Metastatic Uveal Melanoma
This is a FIH, phase I/II, open label, multi-center study of DYP688 as a single agent. The purpose of this study is to c…
Boston, United StatesEst. completion Oct 1, 2027
Uveal Melanoma
This research study is studying a targeted therapy called BVD-523 as a possible treatment for advanced uveal melanoma.
Boston, United StatesCompleted May 5, 2020